Is evidence for homoeopathy reproducible?

Area of Science:

• Complementary and Alternative Medicine
• Immunotherapy
• Allergology

Background:

• Previous trials suggested homeopathy is more effective than placebo.
• Homoeopathic immunotherapy involves using highly diluted substances to stimulate the immune system.
• Allergic asthma, particularly house-dust mite sensitivity, presents a significant clinical challenge.

Purpose of the Study:

• To independently test the reproducibility of previous findings on homeopathy's efficacy.
• To evaluate homeopathic immunotherapy as a complementary treatment for allergic asthma.
• To assess whether observed effects represent true homeopathic activity or potential clinical trial bias.

Main Methods:

• A randomized, placebo-controlled trial involving 28 allergic asthma patients.
• Patients received either oral homeopathic immunotherapy or an identical placebo alongside conventional care.
• Daily visual analogue scale (VAS) for symptom intensity was the primary outcome measure, supplemented by respiratory function and bronchial reactivity tests.

Main Results:

• Homoeopathic immunotherapy showed a statistically significant improvement in symptom intensity compared to placebo within one week (p = 0.003).
• Similar positive trends were observed in respiratory function and bronchial reactivity.
• A meta-analysis combining this trial with two previous ones further strengthened the evidence for homeopathy's effect beyond placebo (p = 0.0004).

Conclusions:

• The reproducibility of positive results challenges the interpretation of clinical trial outcomes in homeopathy.
• Findings suggest homeopathic immunotherapy may offer benefits for allergic asthma beyond placebo.
• Further investigation is warranted to distinguish between true homeopathic activity and potential false-positive trial results.